About
Preclinical Pharmaceutical Developing Bacteria-based Synthetic Positive Selection Screening System
Coltac Therapeutics develops and research solutions of discovering the next generation of molecular glues by harnessing the power of our bacteria-based, synthetic positive selection screening system.
Identity
| Name | Coltac Therapeutics |
|---|---|
| Slug | coltac-therapeutics |
| Type / kind | startup |
| Crunchbase ID | coltac-therapeutics |
| Source _id | j9Bi1rMPwdxp5QdfdzHnC1ZmH3uzeacZXOrfulsewpJjE3cGuntMTi |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Ra'anana |
| HQ address | Ra'anana, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcare
Business models
B2B
Tags
oncologybiopharmaceuticalbiotechnologydrug-discoveryproteins
Funding
| Total raised | $5.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}